New Cancer Research from University of Texas MD Anderson Cancer Center Described [Translational Studies Using the MALT1 Inhibitor (S)-Mepazine to Induce Treg Fragility and Potentiate Immune Checkpoint Therapy in Cancer].

Předmět:	IMMUNE checkpoint proteins CANCER treatment CANCER research REGULATORY T cells UNIVERSITY research
Zdroj:	Immunotherapy Weekly; 6/9/2023, p487-487, 1p
Abstrakt:	Keywords: Cancer; Drugs and Therapies; Health and Medicine; Immunology; Oncology; Pharmacokinetics; Pharmacology; Therapy EN Cancer Drugs and Therapies Health and Medicine Immunology Oncology Pharmacokinetics Pharmacology Therapy 487 487 1 06/05/23 20230609 NES 230609 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A new study on cancer is now available. Pharmacokinetic profiling revealed favorable drug accumulation in tumors to concentrations that effectively blocked MALT1 activity, potentially explaining preferential effects on tumor-infiltrating over systemic Tregs.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu